A Double Blind, Randomized 3rd Party Open, Placebo Controlled, Parallel Group Multiple Oral Escalating Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UK-396,082 In Healthy Subjects.

Trial Profile

A Double Blind, Randomized 3rd Party Open, Placebo Controlled, Parallel Group Multiple Oral Escalating Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of UK-396,082 In Healthy Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 27 Jul 2010

At a glance

  • Drugs UK 396082 (Primary)
  • Indications Thrombosis
  • Focus Adverse reactions
  • Most Recent Events

    • 27 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 21 Apr 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 27 Mar 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top